Annual report pursuant to Section 13 and 15(d)

Earnings Per Share (Tables)

v3.25.0.1
Earnings Per Share (Tables)
 12 Months Ended
Dec. 31, 2024
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share
Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:
(in thousands, except per share data) Year Ended December 31,
2024 2023 2022
Numerator         
Net increase (decrease) in net assets resulting from operations $ 262,966  $ 337,484  $ 102,081 
Less: Total distributions declared (312,244) (278,301) (249,077)
Total Earnings (loss), net of total distributions (49,278) 59,183  (146,996)
        
Earnings (loss), net of distributions attributable to common shares (49,278) 58,593  (146,995)
Add: Distributions declared attributable to common shares 309,413  275,548  246,873 
Numerator for basic and diluted change in net assets per common share $ 260,135  $ 334,141  $ 99,878 
        
Denominator         
Basic weighted average common shares outstanding 161,082  144,091  125,189 
Common shares issuable 517  735  1,470 
Weighted average common shares outstanding assuming dilution 161,599  144,826  126,659 
Change in net assets per common share:
Basic $ 1.61  $ 2.32  $ 0.80 
Diluted $ 1.61  $ 2.31  $ 0.79 
Schedule of Number of Anti-diluted Shares As Calculated Based on Weighted Average Closing Price of Common Stock For the years ended December 31, 2024, 2023 and 2022, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:
  Year Ended December 31,
Anti-dilutive Securities 2024 2023 2022
Unvested common stock options 1,105 1,496 2,085
Restricted stock units — 4,357 —
Unvested restricted stock awards 298 30,028 2,116